153 related articles for article (PubMed ID: 37098593)
21. PAX2 and PAX8: useful markers for metastatic effusions.
Waters L; Crumley S; Truong L; Mody D; Coffey D
Acta Cytol; 2014; 58(1):60-6. PubMed ID: 24334997
[TBL] [Abstract][Full Text] [Related]
22. PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy.
Wang Y; Wang Y; Li J; Yuan Z; Yuan B; Zhang T; Cragun JM; Kong B; Zheng W
J Hematol Oncol; 2013 Aug; 6():60. PubMed ID: 23958394
[TBL] [Abstract][Full Text] [Related]
23. Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors.
Lu H; Allende D; Liu X; Zhang Y
Appl Immunohistochem Mol Morphol; 2020; 28(10):776-780. PubMed ID: 32723981
[TBL] [Abstract][Full Text] [Related]
24. Serous cystadenoma of the pancreas: limitations and pitfalls of endoscopic ultrasound-guided fine-needle aspiration biopsy.
Belsley NA; Pitman MB; Lauwers GY; Brugge WR; Deshpande V
Cancer; 2008 Apr; 114(2):102-10. PubMed ID: 18260088
[TBL] [Abstract][Full Text] [Related]
25. Solid serous cystadenoma of the pancreas: a case report of 2 patients revealing vimentin, β-catenin, α-1 antitrypsin, and α-1 antichymotrypsin as new immunohistochemistry staining markers.
Wu W; Hong X; Li J; Dai M; Wang W; Tong A; Zhu Z; Dai H; Zhao Y
Medicine (Baltimore); 2015 Mar; 94(12):e644. PubMed ID: 25816032
[TBL] [Abstract][Full Text] [Related]
26. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.
Laury AR; Hornick JL; Perets R; Krane JF; Corson J; Drapkin R; Hirsch MS
Am J Surg Pathol; 2010 May; 34(5):627-35. PubMed ID: 20414098
[TBL] [Abstract][Full Text] [Related]
27. Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma.
Peat TJ; Edmondson EF; Miller MA; DuSold DM; Ramos-Vara JA
Vet Pathol; 2017 Jul; 54(4):588-594. PubMed ID: 28346124
[TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine markers expression in pancreatic serous cystadenoma.
Kanehira K; Khoury T
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):141-6. PubMed ID: 21030861
[TBL] [Abstract][Full Text] [Related]
29. PAX2 and PAX8 reliably distinguishes ovarian serous tumors from mucinous tumors.
Wang M; Ma H; Pan Y; Xiao W; Li J; Yu J; He J
Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):280-7. PubMed ID: 24992169
[TBL] [Abstract][Full Text] [Related]
30. Significant variation of immunohistochemical marker expression in paired primary and metastatic clear cell renal cell carcinomas.
Pan Z; Grizzle W; Hameed O
Am J Clin Pathol; 2013 Sep; 140(3):410-8. PubMed ID: 23955461
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine tumors.
Lorenzo PI; Jimenez Moreno CM; Delgado I; Cobo-Vuilleumier N; Meier R; Gomez-Izquierdo L; Berney T; Garcia-Carbonero R; Rojas A; Gauthier BR
Histochem Cell Biol; 2011 Nov; 136(5):595-607. PubMed ID: 21932072
[TBL] [Abstract][Full Text] [Related]
32. EUS-FNA diagnosis of pancreatic serous cystadenoma with the aid of cell blocks and α-inhibin immunochemistry: A case series.
Sydney GI; Ioakim KJ; Michaelides C; Sepsa A; Sopaki-Valalaki A; Tsiotos GG; Theocharis S; Salla C; Nikas I
Diagn Cytopathol; 2020 Mar; 48(3):239-243. PubMed ID: 31785091
[TBL] [Abstract][Full Text] [Related]
33. Serous Cystadenoma of the Pancreas: Potentials and Pitfalls of a Preoperative Cytopathologic Diagnosis.
Lilo MT; VandenBussche CJ; Allison DB; Lennon AM; Younes BK; Hruban RH; Wolfgang CL; Ali SZ
Acta Cytol; 2017; 61(1):27-33. PubMed ID: 27889754
[TBL] [Abstract][Full Text] [Related]
34. Fine-needle aspiration of pancreatic serous cystadenoma: cytologic features and diagnostic pitfalls.
Huang P; Staerkel G; Sneige N; Gong Y
Cancer; 2006 Aug; 108(4):239-49. PubMed ID: 16691573
[TBL] [Abstract][Full Text] [Related]
35. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.
Gonzalez-Roibon N; Albadine R; Sharma R; Faraj SF; Illei PB; Argani P; Ertoy D; Allaf ME; Netto GJ
Hum Pathol; 2013 Dec; 44(12):2651-7. PubMed ID: 24071011
[TBL] [Abstract][Full Text] [Related]
36. Can We Identify Nephrogenic Adenoma in Urine Cytology Specimens? A Study Evaluating Previously Described Cytomorphologic Features in Correlation With PAX8 Immunohistochemical Staining Results.
McCroskey Z; Pambuccian SE; Wojcik EM; Barkan GA
Am J Clin Pathol; 2016 Mar; 145(3):373-8. PubMed ID: 27124920
[TBL] [Abstract][Full Text] [Related]
37. PAX8 is expressed in pancreatic well-differentiated neuroendocrine tumors and in extrapancreatic poorly differentiated neuroendocrine carcinomas in fine-needle aspiration biopsy specimens.
Haynes CM; Sangoi AR; Pai RK
Cancer Cytopathol; 2011 Jun; 119(3):193-201. PubMed ID: 21328566
[TBL] [Abstract][Full Text] [Related]
38. Coexisting pancreatic serous cystadenoma and pancreatic ductal adenocarcinoma: A cytological-pathologic correlation with literature review.
Rowan D; Pant M; Hagen C; Giorgadze T
Ann Diagn Pathol; 2019 Oct; 42():87-91. PubMed ID: 31382079
[TBL] [Abstract][Full Text] [Related]
39. Clear cell endocrine pancreatic tumor mimicking renal cell carcinoma: a distinctive neoplasm of von Hippel-Lindau disease.
Hoang MP; Hruban RH; Albores-Saavedra J
Am J Surg Pathol; 2001 May; 25(5):602-9. PubMed ID: 11342771
[TBL] [Abstract][Full Text] [Related]
40. PAX8 expression in sporadic hemangioblastoma of the kidney supports a primary renal cell lineage: implications for differential diagnosis.
Zhao M; Williamson SR; Yu J; Xia W; Li C; Zheng J; Zhu Y; Sun K; Wang Z; Cheng L
Hum Pathol; 2013 Oct; 44(10):2247-55. PubMed ID: 23849894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
